Treatment of glioblastoma cells with a TUBB4 inhibitor, CR-42-24, reduces the expression of GLUT1; however, TUBB4 expression is unaltered upon treatment with GLUT1 inhibitor fasentin.18 These indicate that GLUT1 may be a downstream gene of TUBB4A. This evidence concerns the gene SLC2A1 and glioblastoma.